(Press-News.org) A new study sheds light on the behavior of yeast cells in the gut, paving the way for new lines of yeast that more efficiently produce therapeutic drugs tailored to address specific diseases.
“Yeast is promising as a drug-delivery platform,” says Nathan Crook, corresponding author of the study and an associate professor of chemical and biomolecular engineering at North Carolina State University. “Previous work has shown that yeast cells can be modified to produce specific molecules in the gut, such as therapeutics that can reduce inflammation, help fight disease, and so on. However, while we know that yeasts can do this, we don’t know how the yeast cells are doing this. Which genes are turned off or on? What is the yeast eating? Is the yeast producing any other molecules that might be harmful?
“Our goal with this project was to measure gene expression of Saccharomyces boulardii (Sb) yeast cells in the gut. That information is critical if we want to engineer these cells to make them more efficient and effective drug-delivery vehicles.”
The researchers chose to work with Sb yeast because it is the only species of yeast that is already in use as a probiotic, but the biochemical processes of the species have not been well studied. For this study, the researchers used an off-the-shelf strain of Sb yeast that had not been genetically modified in any way.
The researchers introduced the Sb yeast cells into laboratory mice that were specially raised to be “germ-free,” meaning that they had no gut microbiome. The researchers then collected fecal and intestinal samples from the mice and used a novel combination of established sampling and analytical techniques to measure the RNA produced by the yeast cells as they passed through the guts of the mice. Because the mice were germ-free, there were no other microbial species in the gut producing RNA, making it easier to identify the RNA from the yeast cells.
“One of the key findings is that we’ve identified which genes in the Sb yeast are much more likely to be activated when in the gut as opposed to other environments. That tells us which sections of DNA are most responsive to the gut environment. And that is useful because we can then target these ‘promoter’ sections of DNA as on-switches that tell the yeast cell when to start producing therapeutic molecules. In other words, we’ve identified the best candidates for helping us ensure the yeast cell is producing medicine when we want it to, which makes it a much more efficient drug-delivery platform.”
The researchers also found that genes in the yeast associated with the production of potentially pathogenic behavior were not activated while in the gut.
“This isn’t surprising, given that Sb yeast is already used as a probiotic – which would be unlikely if it was causing intestinal problems. However, it’s good to establish this before moving forward with additional efforts to engineer Sb cells for drug delivery.”
Lastly, gene activation of the yeast cells in the gut suggests that the gut is not a nutrient-rich environment for the yeast. Specifically, the yeast cells were digesting more lipids than carbohydrates.
“This is not entirely surprising, but it’s important because if we want the yeast cells to essentially serve as factories that produce medicine on-site, then you need those cells to have energy to do their work efficiently. Our findings suggest it may be beneficial to modify the yeast cells so that they can make better use of the complex carbohydrates in the gut ecosystem.
“We’re optimistic about the potential of Saccharomyces boulardii for the development of new pharmaceuticals, and this work provides a roadmap for the most promising paths forward.”
The paper, “Transcriptomic Responses of Saccharomyces boulardii to the Germ-Free Mouse Gut,” is published open access in the journal BMC Genomics. Co-lead authors of the paper are Genan Wang, a postdoctoral researcher at NC State; and Deniz Durmusoglu, a former Ph.D. student and postdoctoral researcher at NC State.
The authors have filed patent applications and invention disclosures related to the engineering of probiotic yeast.
This work was done with support from the National Science Foundation, under grant 1934284; the Novo Nordisk Foundation, under grant NNF19SA0035474; and the National Institutes of Health, under grant 1DP2AT012795-01.
END
How studying yeast in the gut could lead to new, better drugs
2026-02-24
ELSE PRESS RELEASES FROM THIS DATE:
Chemists thought phosphorus had shown all its cards. It surprised them with a new move
2026-02-24
Key takeaways
Precious transition metals like platinum and palladium are used as catalysts to speed up chemical reactions that produce carbon-nitrogen bonds.
UCLA organic chemists have figured out how to make inexpensive phosphine act like a transition-metal catalyst by using a light-reactive molecule to activate it.
The achievement could be useful in the pharmaceutical industry and help bring down the price of some drugs.
A discovery by UCLA organic chemists may one day put catalytic converter thieves out of business. In new research, they’ve used ...
A feedback loop of rising submissions and overburdened peer reviewers threatens the peer review system of the scientific literature
2026-02-24
The process of peer review is vital to contemporary science, but is also under enormous strain. This study uses mathematical models to dissect the threats to the long-term viability of peer review, suggesting paths forward to place peer review on more stable footing.
In your coverage, please use this URL to provide access to the freely available paper in PLOS Biology: https://plos.io/3NUgj2X
Article title: Screening, sorting, and the feedback cycles that imperil peer review
Author countries: United States of America
Funding: This work was partially supported by NSF (www.nsf.gov) awards SES-2346645 ...
Rediscovered music may never sound the same twice, according to new Surrey study
2026-02-24
Rediscovering long forgotten music does not mean recovering how it was meant to be performed, and that is a major challenge for the arts, finds a new study from the University of Surrey. An expert found that rediscovered music comes with no shared understanding for how it should sound, leaving performers to make radically different interpretive choices that reshape the work itself.
In an article published in Performance Research: A Journal of the Performing Arts, a researcher focused on a little-known piano miniature by Surrey-based British composer ...
Ochsner Baton Rouge expands specialty physicians and providers at area clinics and O’Neal hospital
2026-02-24
BATON ROUGE, La. – As part of its continued investment in specialty care access for the Baton Rouge community, Ochsner Baton Rouge welcomes several new physicians and advanced practice providers who are now accepting new patients.
Alexis Ambeau, PhD, practices neuropsychology at Ochsner Health Center – O'Neal, specializing in assessing adults with a range of conditions, including neurodegenerative disorders and other dementias, movement disorders, multiple sclerosis and other autoimmune disorders, traumatic brain injury, stroke, central nervous ...
New strategies aim at HIV’s last strongholds
2026-02-24
A new study has overcome a long-standing challenge—how to isolate and study elusive HIV-infected cells called authentic reservoir clones (ARCs) that evade the immune system, making the disease difficult to cure. Researchers from Weill Cornell Medicine, Rockefeller University, and collaborating institutions offer a detailed look into these hidden HIV‑harboring cells and show that some may be more vulnerable to immune destruction than previously believed.
The findings, published Feb. 24 in Nature, detail how the researchers ...
Ambitious climate policy ensures reduction of CO2 emissions
2026-02-24
Global efforts to combat climate change in the last two decades have contributed to considerably cutting carbon emissions, according to a new study conducted primarily by scientists from Germany and the United Kingdom. The participating researchers investigated which climate policies were particularly effective. Reduced emissions have generally been the result of ambitious, i.e., larger and stricter climate policy portfolios. In addition, countries targeting the largest sources of emissions were particularly successful, according to the experts from Heidelberg University, who played a major role in the study.
The research findings are based on a statistical analysis ...
Frontiers in Science Deep Dive webinar series: How bacteria can reclaim lost energy, nutrients, and clean water from wastewater
2026-02-24
Wastewater contains untapped resources that, if reclaimed, could power agriculture, global sanitation, and its own treatment to help us meet UN SDG goals.
This is according to a new Frontiers in Science lead article in which researchers Prof Uwe Schröder, Prof Falk Harnisch, Dr Elizabeth Heidrich, and Dr Deepak Pant examine how microbial electrochemical technologies (METs) can convert organic waste streams into electricity, fuels, fertilizers, and usable water more efficiently. Pilot deployments—from the UK’s Glastonbury Festival to field trials in Uganda, Kenya, and South Africa—are demonstrating its ...
UMaine researcher develops model to protect freshwater fish worldwide from extinction
2026-02-24
Whether it’s redfin pickerel in the Kennebec River or sturgeon in the Great Lakes, nearly one-third of freshwater fish species are facing possible extinction, threatening food supplies, ecosystems and outdoor recreation.
As conservationists work to preserve these species, the University of Maine assistant professor Christina Murphy asked herself if there was an easier way to identify threats to fish before they become endangered.
After five years of data collection, programming and testing, Murphy and her colleagues developed a computer model that identifies potential threats to more than 10,000 freshwater species worldwide. Encouragingly, the majority of species accounted for ...
Illinois and UChicago physicists develop a new method to measure the expansion rate of the universe
2026-02-24
We have known for several decades that the universe is expanding. Scientists use multiple techniques to measure the present-day expansion rate of the universe, known as the Hubble constant. These methods are internally consistent and based on the same physics, so all observed values of the Hubble constant should agree. But those that come from early-universe datasets disagree with those that come from late-universe datasets. This problem is known as the Hubble tension and is considered to be one of the most significant open questions in cosmology.
Now a team of astrophysicists, cosmologists, and physicists at The Grainger College of Engineering at the University of Illinois Urbana-Champaign ...
Pathway to residency program helps kids and the pediatrician shortage
2026-02-24
With children across the U.S. facing long wait times for medical care due to a shortage of pediatricians, UC San Francisco has launched a medical education program designed to strengthen the pediatric workforce and improve childhood health outcomes.
The Pediatric Specialized Training and Advancement to Residency Track (Peds-START) is the only program of its kind in the West and provides early mentorship, individualized training, and a pathway into the UCSF pediatric residency program.
Nationwide, there are just 82 pediatricians per 100,000 children, ...